All News

The use of the HPV vaccine may be creating herd immunity, protecting unvaccinated women.

Measles is still very rare in the United States, but most cases involved either someone who was not vaccinated or whose status is unknown.

NCPA CEO B. Douglas Hoey, RPh, MBA, discusses the problems and opportunities facing independent pharmacies.

Pharmacists can help patients-but only the ones they have time to reach.

Why are Americans shouldering the burden of paying for drug innovations?

A new ally in building up independent pharmacies.

Two groups are joining forces to enhance medication management.

What you (and your patients) need to know about flu vaccines this year.

What you need to know when filling prescriptions for Fido and Fluffy.

The twice-annual event will feature a new incentive this October.

Edaravone has been approved for patients with amyotropic lateral sclerosis.

Antimicrobial susceptibility testing (AST) for newer antibiotics is falling behind because there is a lag time between FDA approval and inclusion in commercial AST devices.

High-alert drugs pose a significant threat to patient safety. There are safeguards that pharmacists should put in place to reduce the risk.

Dual antithrombotic therapy using dabigatran significantly reduces risk of bleeding compared to triple therapy using warfarin.

The risk of intraocular bleeding was reduced by one-fifth when using newer anticoagulants versus warfarin in a new study.

What you need to know about the upcoming NCPA convention.

Pharmacists are uniquely poised to combat the opioid crisis. Here's what pharmacists (and Congress) can do about it.

When FluMIst was discontinued, there were worries that flu vaccination rates would drop.

From the Drug Topics archives, one of most popular features in our history returns.

Governor Jerry Brown signed the bill, but will it actually lower drug costs?

Two pharmacists were charged in two different fraud cases.

Kiriko is recalling all lots of its weight-loss supplement.

A study finds that a significant number of FDA-mandated studies are unfinished.

Your Patients want to hear from you! Are you getting the word out?

The new ScriptPath Prescription Schedule system is expected to help patients and pharmacists.

A study commissioned by the NCPA shows the effect of DIR fees.

Proponents argue that limits reduce the risk of addiction, but are they keeping pharmacists from caring for their patients?

What you need to know about the latest new medications.